Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples